Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 22, 2015 10:23 PM ET


Company Overview of Pfizer Inc.

Executive Profile

Ian C. Read

Chairman, Chief Executive Officer and Chairman of Executive Committee, Pfizer Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Ian C. Read has been the Chief Executive Officer of Pfizer Inc., since December 5, 2010. Mr. Read served as the President of Pfizer Inc. from December 5, 2010 to December 12, 2011. He is the Chairman and Chief Executive Officer at Thiakis Limited. He served as Group President of Worldwide Biopharmaceutical Businesses at Pfizer Inc., since October 2009. He served as Senior Vice President of Pfizer Inc. from August 2006 to December 5, 2010. He served as President of ...

Corporate Headquarters

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships

Chairman and Chief Executive Officer
Director, Chairman of Nominating & Corporate Governance Committee and Member of Executive Committee
Chairman, Chief Executive Officer and Chairman of Executive Committee


BS 1974
University Of London

Other Affiliations

Annual Compensation

Total Annual Compensation$1,815,000

Stocks Options

Restricted Stock Awards$6,447,998
All Other Compensation$391,828
Exercised Options$285,855
Exercised Options Value$6,104,895
Exercisable Options$1,959,743
Exercisable Options Value$21,524,559
Unexercisable Options$3,632,687
Unexercisable Options Value$19,245,238
Total Value of Options$46,874,692
Total Number of Options$5,878,285

Total Compensation

Total Annual Cash Compensation$5,206,828
Total Short Term Compensation$1,815,000
Other Long Term Compensation$6,839,826
Total Calculated Compensation$23,283,048

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Paul Bulcke B.E.Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee
Nestlé S.A.
Alan George Lafley Chairman, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pfizer Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at